Sign In
Buy CMPS
$12.69
-0.640 (-4.80%)
At Close: Jun 03, 2026
COMPASS Pathways appoints Wayne J Riley MD to its Board of Directors
07:01am, Thursday, 01'st Apr 2021Compass Pathways: rNPV Probabilities Of Success Are Underestimated
03:11pm, Wednesday, 17'th Mar 2021
Market participants are underestimating COMP360 probabilities of success in rNPV-models.
U.S. IPO Week Ahead: The Spring IPO Market Starts To Thaw In An 8 IPO Week
08:25am, Saturday, 13'th Mar 2021
The IPO market starts to pick back up with eight IPOs scheduled to raise $2.2 billion in the week ahead. Street research is expected for one company on Sunday, 3/14.
7 Healthcare Stocks to Buy and Hold for the Long Term
11:43am, Friday, 12'th Mar 2021
These steady, strong healthcare stocks are great picks for investors to buy and hold onto for at least the next five years. The post 7 Healthcare Stocks to Buy and Hold for the Long Term appeared firs
COMPASS Pathways plc announces financial results and business highlights for fourth quarter and year-end 2020
07:00am, Tuesday, 09'th Mar 2021
Highlights include continued progress with phase IIb psilocybin therapy clinical trial, launch of first Centre of Excellence, and expansion of Discovery Center Highlights include continued progress wi
3 Outside-the-Box Stocks to Buy Now
07:20am, Wednesday, 03'rd Mar 2021
Three stocks are rich in growth potential, but everyone is afraid of buying them.
COMPASS Pathways plc to announce fourth quarter and full year 2020 financial results on 9 March 2021
07:00am, Tuesday, 02'nd Mar 2021
New York, March 02, 2021 (GLOBE NEWSWIRE) -- London, UK – 2 March 2021
COMPASS Pathways plc to participate in Cowen's 41st Annual Health Care Conference
07:00am, Friday, 26'th Feb 2021
New York, NY, Feb. 26, 2021 (GLOBE NEWSWIRE) -- George Goldsmith, Chairman & CEO, to participate in Neuropsych Panel discussion
COMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists
07:02am, Tuesday, 09'th Feb 2021
COMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists
COMPASS Pathways announces publication in Frontiers in Psychiatry of paper on therapist training programme for psilocybin therapy
07:00am, Wednesday, 03'rd Feb 2021
COMPASS Pathways announces publication in Frontiers in Psychiatry of paper on therapist training programme for psilocybin therapy
5 Groovy Psychedelic Stocks to Buy
01:19pm, Friday, 08'th Jan 2021
Psychedelic stocks could have another “far out” year ahead with U.S. FDA support, as well as more clinical trials that are under way. The post 5 Groovy Psychedelic Stocks to Buy appeared first on
COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care
COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care
COMPASS Pathways plc to participate in HC Wainwright and ICR investor conferences
07:30am, Wednesday, 06'th Jan 2021
London, UK, Jan. 06, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health,
Psilocybin Will Change Mental Health, Compass Pathways Could Be At The Forefront
02:35am, Friday, 01'st Jan 2021
Psilocybin Will Change Mental Health, Compass Pathways Could Be At The Forefront
